Explore Converge Bio careers and hiring status. Find jobs at Converge Bio and official application links when roles are open. Funding stage: Series A. Headcount: 11-50. Includes the official careers page link. Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs faster, utilizing Large Language Models specifically trained on biological languages.
This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.
Converge Bio is a Series A stage AI startup, founded in 2024, with $30M in total disclosed funding. Its most recent round was a $25M Series A in Jan 2026. It has no open roles listed at the moment; new Converge Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.
Company profile last updated on Aug 9, 2026.
Converge Bio careers and hiring status: no open roles are currently listed here, but you can review the company profile and check the official career page for the latest openings. Official careers page
Converge Bio is an biotech company. Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs faster, utilizing Large Language Models specifically trained on biological languages.
Open positions
Check the official career page, browse adjacent companies, or subscribe for new openings.
Candidate questions
Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs faster, utilizing Large Language Models specifically trained on biological languages.
Converge Bio does not have open roles listed on our platform right now. Visit the official company website or career page for the latest openings, or subscribe to get notified when new roles are posted.
Converge Bio has raised $30M in total. The latest known stage is Series A.
Converge Bio reports an employee count of 11-50.
Converge Bio was founded in 2024.
Converge Bio is associated with Biotech, Generative AI, Healthcare, Machine Learning, B2B SaaS.
Company context
Converge Bio is a Series A stage AI startup, founded in 2024, with $30M in total disclosed funding. Its most recent round was a $25M Series A in Jan 2026. It has no open roles listed at the moment; new Converge Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.